🇺🇸 FDA
Patent

US 11162079

Blood type O Rh-hypo-immunogenic pluripotent cells

granted A61KA61K35/545

Quick answer

US patent 11162079 (Blood type O Rh-hypo-immunogenic pluripotent cells) held by The Regents of the University of California expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K35/545